Surface plasmon resonance (SPR) [1] is a direct sensing analysis technique with a unique combination of features. Since it is a label-free technique it does not involve changes of the structure of the (bio)molecules that may be involved in the biomolecular interaction and the technique yields information on the concentration (how many analyte molecules are present in a complex sample), the affinity (how strong an interaction is) and the kinetics (how fast an interaction is) of biomolecules and their interactions [2] .
Introduction
Surface plasmon resonance (SPR) [1] is a direct sensing analysis technique with a unique combination of features. Since it is a label-free technique it does not involve changes of the structure of the (bio)molecules that may be involved in the biomolecular interaction and the technique yields information on the concentration (how many analyte molecules are present in a complex sample), the affinity (how strong an interaction is) and the kinetics (how fast an interaction is) of biomolecules and their interactions [2] .
Almost every SPR-experiment applies the same basic procedure in which the first step, the so-called immobilization (see also Chapter 6), involves covalent binding of a ligand to the surface of the sensor followed by the so-called analysis cycle [3] . In order to detect the presence or a specific interaction of a 221 certain analyte in a sample, prior to analysis, a capturing entity (the ligand) should be immobilized on the sensor surface [4] . Although the ligand can be any type of (bio)molecule, more than 80% of the capturing agents used in SPR analysis are related to proteins (e.g. antibody, antigen, receptor, peptide).
In the previous chapter, various chemical protocols are given for the attachment of ligands to the sensor surface. The present chapter covers the analysis cycle for measuring biomolecular interactions with SPR detection. After a discussion of the analysis cycle, it focuses on the use of SPR in immunoassays, including the latest developments of new SPR instrumentation: scanning SPR microarray imaging for monitoring autoimmune diseases. SPR imaging in combination with microarrays for genomics and proteomics applications is rapidly evolving. To demonstrate the features and benefits of multianalyte microarray-based biomolecular interactions, the analysis cycle of autoimmune antibody interactions in serum monitored with SPR imaging is discussed.
The Analysis Cycle
After immobilization of a preferably pure ligand, the analysis cycle starts with the introduction of a buffer solution in the measurement cell, in order to generate a (stable) baseline. Subsequently, a sample, containing the ligand's binding partner (the analyte), is introduced into the measurement cell and the analyte binds to the ligand, leading to the selective accumulation of the analyte on the sensor surface. This causes an increase in the refractive index near the sensor surface. This change in refractive index can be measured in real time. The selectively accumulated mass on the sensor chip surface (which is generally expressed in pg Á mm À2 ) correlates linearly with the change in the refractive index near the sensor surface measured by the SPR instrument [5] . A rule of thumb is that for an instrument that uses light with a wavelength of 670 nm, 1 ng Á mm À2 protein gives a signal of about 100 millidegrees (m1) angle shift. In Biacore instruments, 10 resonance units (RU) correspond to approximately 1 m1 SPR angle shift. When light of another wavelength is used then the angle shift should be calibrated.
The response in SPR experiments of which a typical example is shown in Figure 7 .1 directly reflects the change in the refractive index of the liquid phase near the surface of the sensor chip. The observed response is the sum of the response caused by association of analyte with the ligand and that caused by the difference in refractive index between the solution and the baseline buffer. The latter is called the ''bulk effect'' [6] and is caused by the presence of dissolved material including buffer components, biomolecules and salt. The bulk effect needs to be subtracted from the observed response in order to measure the true binding of the analyte molecules. If a reference channel is available in the SPR instrument, then the bulk effect can be determined accurately. This reference channel may also correct for non-specific adsorption of sample components to the surface of the sensor chip. Using baseline buffer as the solvent of the analyte will minimize the bulk effect. In experiments for qualitative determination of whether the analyte will bind or not, careful adjustment of the buffer is not critical. However, for quantitative kinetic determinations in which a series of different analyte concentrations are used, it is important that buffer exchange is performed reliably, for instance by dialysis or gel filtration. Tuning the refractive index of the background buffer to mimic the sample and using the baseline buffer for dilution of the sample is a way to minimize the bulk effect.
After the association process, buffer solution is introduced into the system, which initiates the dissociation phase. During the dissociation phase, the specifically and non-specifically bound compounds may detach from the surface, resulting in a decrease in response. Because in the dissociation phase the background buffer is usually the same as the buffer used during the baseline measurement, the exact amount of associated material can be In experiments where the sensorgram is compensated for bulk shift effects (for instance, when multichannel instruments are used in which one channel serves as reference), the association and dissociation phase of the sensorgram allow the calculation of the reaction rate and the thermodynamic equilibrium constants. If this is available, it is performed using instrument-specific software. Alternatively, it can be performed with general kinetic evaluation software. Furthermore, from the sensorgram the effectiveness of the regeneration procedure can be determined. Incomplete regeneration will result in residual analyte and/or non-specifically bound components on the sensor surface, which will increase the baseline, whereas too harsh sensor regeneration will result in a decreased binding capacity of the sensor in subsequent analysis cycles 1 .
Buffer Solutions for Measuring the Analysis Cycle

Baseline Buffer
The running, background or baseline buffer should create optimal conditions for the binding of the ligand to the analyte. For biomolecular interactions the baseline buffer is usually a physiological buffer with sufficient salt and (near-) neutral pH. Phosphate-buffered saline (PBS) is a standard baseline buffer. Alternatively, 10 mM HEPES-KOH (pH 7.4), 0.15 M NaCl is often used. The addition of a surfactant, e.g. Tween 20 (0.03-0.05%) to the buffer is favored in order to minimize non-specific binding. The surfactant not only enhances the ratio between specific and non-specific binding but also helps to prevent air bubble adsorption on the surface. However, surfactants should not be added if hydrophobic surfaces are used for non-covalent attachment of membranebound components. Moreover, a surfactant should not be used during the immobilization cycle (see Chapter 6) . Sometimes 3 mM EDTA is added to trap remaining bivalent cations (e.g. Mg 21 or Ca 21 ), which may interfere with the carboxylate groups in the hydrogel layer. Blocking components may help reducing non-specific binding, e.g. 3% BSA or HSA if patient serum is used.
In the experiments on samples from rheumatoid arthritis (RA) patients described in Section 7.6, normal sheep serum was applied.
All buffer solutions should be prepared with Milli-Q water and preferably filtered through a 0.22 mm filter and degassed before use.
Regeneration Solution
For repeated use of the same sensor chip, the surface should be regenerated by removal of analyte and any other non-covalently bound material. However, the ligand should be kept intact and should not be inactivated or denatured during the regeneration phase. Commonly used solutions for regeneration include lowpH buffers, e.g. 10 mM glycine-HCl (pH 1.5). Optimal sensor regeneration includes a pH shock and regeneration is preferably performed as two consecutive steps of, for instance, 30 s each, rather than one step of 60 s. If a negatively charged gel-type sensor is used, not only the specific bond between ligand and analyte will break during low pH regeneration, but also the hydrogel will collapse and the analyte will be more or less squeezed out of the hydrogel. If the ligand or analyte cannot withstand low pH, sometimes a high alkaline pH is used, e.g. 10 mM NaOH (pH 4 11). Alternative regeneration solutions have a high salt concentration and the salts used include chaotropic agents that are chemicals, such as urea and guanidine hydrochloride, that disrupt hydrogen bonding in aqueous solutions. It should be noted that concentrated solutions of these agents may denature proteins, because they also interfere with hydrophobic interactions.
SPR-based Immunoassays
In general, an immunoassay is a laboratory technique based on the binding between an antigen and its homologous antibody in order to identify and quantify the specific antigen or antibody in a sample. In classical immunoassays, the detection of the concentration of an analyte relies on signals generated by various labels (fluorescent dyes, enzymes or radioisotopes) attached to antigens or antibodies [7] . Labeling may disrupt the binding sites involved in the interaction. Moreover, labeling induces heterogeneity of the biomolecular interaction because in most cases labeling of a specific molecule (e.g. an antibody) is not homogeneously distributed. In addition, the label itself might interact with the capturing ligands, leading to false positives. A way to circumvent some of the problems is to use a labeled secondary binding molecule, but this extra step requires an additional, high-affinity binding compound and it will also increase the required analysis time. SPR-based biosensors measure protein-protein binding directly as a shift in surface-bound masses. Since SPR is a label-free analysis technique, it is preferred for studying biomolecular interactions.
The observed binding rate of analyte to the ligand at the sensor surface may be limited either by the rate of interaction (kinetics) or the rate of supply of analyte to the surface (mass transport). Large amounts of ligand on the surface lead to higher interaction rates and low sample flow rates lead to a slower supply of analyte to the surface. Both of these factors contribute to mass transport-limited binding. These considerations are important for kinetic evaluation of association rate constants k a and dissociation rate constants k d . If mass transport limits the observed binding rates, then the apparent association rate constant from the simple model A + B # AB will be lower than the true value. A high ligand loading leads to rebinding effects during the dissociation phase and lower apparent dissociation rate constants will be measured for AB # A + B. In order to prevent rebinding, the ligand which is immobilized to the surface may be added to the dissociation buffer too. Rebinding has been demonstrated at high ligand loadings in hydrogels. It affects the calculation of the affinity constant dramatically and deviations of as high as two orders of magnitude have been reported [8] .
Concentration measurements require a high loading of ligand on the surface and constant hydrodynamic conditions (flow rate or mixing speed). If the analyte dissociates from the surface it should not rebind at free sites while diffusing out of the hydrogel. Kinetic rate experiments require a low surface loading of the ligand, ideally the lowest ligand loading that still gives a measurable response after analyte binding. Mass transport limitation and other kinetic evaluation considerations are treated in detail in Chapters 4 and 5. Figure 7 .2 shows different assay formats that are appropriate for SPR including direct, competitive, inhibition and sandwich assays.
Direct Assay
The direct assay is described by A + B # AB. In this type of assay, antibodies directed against the antigen are immobilized on the sensor surface (¼ ligand). Sample solution containing the antigen (analyte) is then incubated with the sensitized sensor surface. The signal increase resulting from antigen binding correlates with the amount of antigen in the sample. Direct assays can also be designed with the antigen coupled to the surface and detection of the binding of the specific antibody. This is the case in the example shown in Section 7.6 of an immunoassay for the monitoring of autoimmune autoantibodies in the serum of rheumatoid arthritis patients.
Competition Assay
This type of assay is typically applied for the detection of low molecular weight antigens that do not generate sufficient signal, while accumulating at the sensor surface. In this assay format specific antibodies are immobilized on the sensor surface and sample solution that contains the antigen is mixed with an antigen conjugate. Because of its high molecular weight, the conjugate enhances the SPR angle shift. The antigen-conjugated antigen mixture is incubated with the sensor surface. The difference in signal between a reference sample containing only conjugated antigen and the sample solution indicates the amount of antigen in the sample. In this assay, high antigen concentrations in the sample will result in low signals (less conjugated antigen can be bound).
Competition assays are often used for the detection of toxic compounds (see also examples in Chapter 11). The maximum signal is generated when no free (toxic) analyte is present. When the signal is too low, possibly the analyte is present in the sample or the ligands are denatured or poisoned by the sample and no longer active while the analyte is not present. Both outcomes are harmful and will require action. If the competition assay shows a response of the unconjugated antigen as in the direct assay, then severe calibration procedures have to be performed. Preferably in SPR competition immunoassays the conjugated antigen is a large refractive index label (e.g. a latex bead or gold nanoparticle) loaded with the antigen.
Inhibition Assay
In this assay format, the target antigen is immobilized on the sensor surface. Sample solution containing the antigen is mixed with specific antibodies in excess and incubated with the sensor surface. Antibodies will bind both to antigen in solution and to antigen that is bound to the sensor surface. The difference in signal between a blank sample that does not contain the antigen and the sample solution indicates the amount of antigen in the sample. In this assay, high antigen concentrations in the sample result in low signals (less antibodies remain to bind to the surface). Because antibodies have high molecular weight, their binding is directly detected.
Sandwich Assay
In sandwich assays, antibody molecules against the analyte are immobilized on the sensor surface, capturing the analyte molecules when sample solution is incubated with the sensor surface. In the next step, a secondary antibody binds specifically with either the antigen or the antigen-bound antibody. The antigen is captured by a sandwich of two antibodies. Only very high affinity capture antibodies should be used, in order to avoid a mixture of affinities of each component in the sandwich. Several steps can be build in, but this complicates the analysis.
Often, a highly specific goat/rabbit/sheep anti-mouse IgG is immobilized as the first capturing agent which traps a monoclonal (mouse) antibody for the antigen. Streptavidin-biotin linkers are often used because of the high affinity constant, which will not interfere with the rate and equilibrium constants of the analyte-ligand pair. The increase in signal (as a result of antigen binding) is proportional to the amount of antigen in the sample. Washing the surface with buffer is followed by the injection of a secondary antibody. The high molecular weight of the secondary antibody is usually sufficient for monitoring the binding process. For further signal enhancement, antibody conjugates with colloidal gold or latex particles as refractive index label can be used [9] .
Detection of Multiplex Analysis Cycles Using
Scanning SPR Imaging SPR imaging can be considered as a new trend (see Chapter 12), although the principle was published decades ago [10, 11] . Currently computers are fast enough to process digital images allowing kinetic measurements of biomolecular interactions in real time. This allows the monitoring of multiple analysis cycles on a microarray by an SPR imaging instrument. In our studies, the instrument for biomolecular interaction sensing by imaging SPR (IBIS iSPR, IBIS Technologies, Hengelo, The Netherlands) is used for this purpose and is represented schematically in Figures 7.3 and 7.4. Fixed-angle instruments in the Kretschmann configuration (Chapter 3) are based on the relationship between a small change in the intensity of the reflected light and the mass of bound analyte, i.e. a fixed incident light angle is employed and mass changes are estimated from the intensity of the reflected light. However, the applicable dynamic range and linear relationship of this experimental setup are limited [12] and the optimal incident angles of each spot of a microarray differ considerably when ligand or analyte panels with different molecular weights are monitored, as explained in Chapter 3. Therefore, choosing one fixed angle to monitor many biomolecular interactions in a microarray will result in only qualitative data. Kinetic rate constants, however, require accurate quantitative data including subtraction of ''bulk effects'' for all the spots of the microarray simultaneously.
Dynamic Range of Scanning SPR Imaging
The continuous SPR dip angle scanning mode of the IBIS iSPR provides a large dynamic range, thereby facilitating accurate, simultaneous measurements of, for instance, the presence and concentration of large proteins and small peptides in the same sample.
In Figure 7 .5, the difference in refractive index dynamic range of angle scanning and fixed-angle measurements is shown. The actual SPR angle depends on the refractive index in the evanescent field of the liquid-gold interface and microarrays spotted with different ligands show an initial distribution of shifts resulting in baselines at different angle positions. A problem exists when the biomolecular interaction is followed at fixed angle caused by the non-linear shape of the SPR curve as the baselines from spots of different ligands and immobilized biomolecular masses show different levels of reflectivity. In SPR imaging instruments, the SPR angles of many regions of interest (ROIs) should be monitored simultaneously. Comparison/subtracting baselines of different reflectivities is essentially incorrect. In fact, the slope of the reflectivity vs. angle curve is not constant and every spot requires its own calibration.
The only reliable parameter that directly reflects the concomitant mass change on an SPR sensor is the SPR angle [13] . Thus, only when the SPR angle is monitored for all spots on a microarray independently can the magnitude and affinity of biomolecular interactions be reliably compared among all spots of the microarray. In the IBIS instrument, the SPR angle of all spots of a microarray can be determined continuously. Thanks to its novel angle-scanning principle with fitting algorithms to calculate the resonance angle of the SPR dip for each ROI, this instrument quantifies the protein mass distribution on the microarray directly. The unique, innovative character of the IBIS imaging SPR instrument lies in the accuracy of SPR angle determination of multiple ROIs in combination with real-time imaging of the complete sensor surface. Inspection of the sensor surface using the microscopic SPR image shows the quality of spots (in terms of coating homogeneity), which is an important feature for generating reliable data (see Figures 7.7, 7.8 and 7.9) . SPR angles of microarrays of more than 500 ROIs can be determined simultaneously, with the maximum number of ROIs being limited by the computing power and the lateral resolution of the SPR technique.
In Figure 7 .6, an image of a microarray is shown, which is spotted, in situ, in the IBIS iSPR instrument. Under scanning conditions, only homogeneous spots with equally distributed pixel intensities give reliable SPR results. A special needle in the liquid handling system automatically spots about 50 nl on a defined location creating the microarray. Drying of the spots can be prevented if the humidity is close to 100%. Evaporation can be delayed by applying non-interfering compounds in the spotting buffer, e.g. glycerol. However, this may impair the reproducibility of the results. In combination with angle scanning and inspection of the SPR dip in terms of depth and width, an indication of the quality of the sensing surface can be obtained. If, e.g., bare gold surfaces are used for ligand immobilization, often cauliflower images can be observed caused by irreproducible drying effects which can result in unreliable sensorgrams. Preferably hydrophilic coatings such as hydrogels are applied for optimal results. The best contrast can be obtained when homogeneous intensities in one spot are at the left flank of the SPR curve. If the light is not homogeneously distributed over the entire surface, it has an effect on the shape (width) of the reflectivity vs. angle plot or SPR dip, but will not affect the minimum resonance condition.
Liquid Handling Procedures
For the IBIS iSPR instrument, different types of flow cells and cuvettes are available and alternatively the instrument can be combined with ''lab-on-achip'' devices for controlling the sample flow over a microarray. Flow cells proved to be the best with regard to performance, accuracy and precision, providing the lowest limit of detection and best response stability. Cuvettebased systems offer the user maximum flexibility. An advantage of a cuvettebased systems for studies of kinetic rate constants is that higher mass transport can be obtained towards the interaction site [14] . A disadvantage is that the mixing parameters such as injection, needle height and mixing speed need to be optimized and controlled in order to prevent shear stress at the sensor surface. For example, particles in the sample can hit the sensor surface, leading to damage of the microarray.
Determination of the Limit of Detection Using Multiplex Analysis Cycles
In order to obtain an indication of the limit of detection (LOD) a microarray containing various densities of two different ligands was spotted on a sensor chip. Regeneration of the sensor with 10 mM glycine-HCl (pH 1.5) provided the ability to test several antibody concentrations on one sensor chip. Figure 7 .7 shows the sensorgram [angle shift (m1) as a function of time (s)] of eight analysis cycles of the interaction of the biotinylated peptides and -proteins with an anti-biotin antibody. The different curves represent the interaction with the various amounts of biotinylated peptides spotted using Top Spot [15, 16] as indicated in the figure caption. The curves varying over time (x-axis) represent the different concentrations of the analyte, anti-biotin IgG. From the analysis cycles of every spot, in principle overlay plots of the interactions with the different analyte concentrations can be generated in order to calculate the onand off-rate constants and affinity equilibrium constants. The affinity constants can be compared with a ''one-shot'' or single injection analysis, a term recently introduced by Bio-Rad's Proteon system. When a serially diluted ligand is immobilized on the surface, the LOD can be expressed as the smallest change in refractive index of the bulk solution or refractive index change in the evanescent field caused by accumulated mass.
As indicated before, if compounds with an increased refractive index replace the background electrolyte buffer solution, a linear relationship exists between the surface coverage (in %) and the molecular weight of the adsorbate. Therefore, a low molecular weight compound (e.g. a small peptide) will contribute less to the accumulated mass per surface area than a high molecular weight compound (e.g. an immunoglobulin). The LOD can be used to characterize an instrument; however, in Chapters 4 and 5 it has been shown that the LOD also depends strongly on the affinity constant of biomolecular Figure 7 .8) at different ligand and analyte concentrations for the determination of the on and off rate constants. Injection of a single analyte was done, which is similar to the one-shot analysis approach as described in Chapter 12. An injection of the highest analyte mouse anti-biotin mouse IgG (150 kDa) concentration (133 pM) resulted in a gradual decrease in responses of the spots loaded with different ligand biotinylated peptide (2.4 kDa) concentrations obtained by spotting using Top Spot [14, 15] of 417, 208, 104, 52 and 26 fmol and two controls, non-biotinylated peptide and the background. After this first analysis cycle, a lower mouse (53 pM) anti-biotin mouse IgG (150 kDa) analyte concentration was injected. Only non-specific dissociation can be observed at higher concentrations of the analyte. In total eight analysis cycles were carried out over the range of 133, 53, 13, 5.3, 1.3, 0.53, 0.13 and 0 pM anti-biotin mouse IgG. Each curve shows the transient 2 m1 response as a result of the change in flow direction. The few spikes are caused by air bubbles disturbing the SPR signal. The inset shows the dose-response curves of the spots as obtained from this sensorgram after a fixed interaction time just after the association phase. In Figure 7 .8, the SPR view of this microarray is shown.
interactions [14] . In our test system using the biotin-streptavidin pair, the specifically bound analyte will not dissociate significantly because of the high affinity constant of this couple. At high concentrations of the analyte only a low non-specific dissociation effect occurs, as shown in Figure 7 .7.
The molecular mass of the analyte (in this case the anti-biotin IgG, B150 kDa) gives an indication of how many molecules are needed to obtain a significant response compared with the signal-to-noise ratio. The amount of analyte bound to the immobilized ligand can be derived from the measured angle shift; 1 m1 ¼ 10.8 pg mm Figure 7 .7 shows the importance of both a balanced combination of the ligand and analyte concentrations for concentration measurements (maximum angle shift) and kinetic parameter determination (low rebinding, low mass transport limitation). Figure 7 .8 shows the corresponding fluorescence image after removing the sensor chip from the system. More on combining fluorescence detection and SPR excitation can be found in Chapter 9.
Secondary antibodies can be used not only to introduce fluorescent labels to check the system but also for linking to refractive index labels such as latex particles and colloidal gold to improve sensitivity (see Section 7.4). The secondary antibody linked to the mass label will induce a measurable shift, thereby improving the LOD if the mass label fits into the evanescent field and in the hydrogel. The use of secondary antibodies can even increase the specificity of a reaction; however, an additional interaction step has to be included which overrules the favorable label-free one-step measurement. The application of SPR imaging for multi-analyte detection in one step is shown in the following section. 
Monitoring of Autoantibodies in Serum of Rheumatoid Arthritis Patients
The potency of SPR imaging is demonstrated by monitoring the analysis cycles of serum autoantibodies of rheumatoid arthritis (RA) patients that bind specifically to citrullinated peptides in a single step. Autoimmune diseases are characterized by the presence of high-affinity autoantibodies directed against self-proteins, such as rheumatoid factor for RA [17] , Sm for systemic lupus erythemathosus (SLE) [18] and Ro/SS-A and La/SS-B for Sjo¨gren's syndrome [18] . Although at least some autoantibodies are known to be involved in cell and tissue damage, their mechanistic role in the pathogenesis of the disease is generally not known [19] . Nevertheless, the specificity of autoantibody responses highlights their potential as important tools for improved diagnosis, disease classification and prognosis. Miniaturized multiplex assays can deliver a fingerprint of a patient's autoantibody repertoire requiring only a limited amount of patient material. During the last decade, various research groups have made important contributions to the application of multiplex assays for autoantibody detection. In 2002, Robinson et al. employed protein and peptide ligand arrays, representing candidate autoantigens, to survey autoantibody binding [20] . Arrays of in situ synthesized peptides can also be generated with photolithography to perform antibody characterization [21] . Another approach is to apply ''virtual arrays'' in a homogeneous assay system with addressable beads [22] . However, in these systems at least one of the interactants has to be labeled, which may disrupt the binding sites involved in the interaction, leading to false negatives. In addition, the label itself might interact with the immobilized proteins, leading to false positives [23] . A way to circumvent these problems is to use a labeled secondary binding molecule, which might result in improved assay sensitivity. In this section, scanning SPR microarray imaging is used to measure the presence of anti-citrullinated protein antibodies (ACPA) in the sera of RA patients. Recently, it was shown that the so-called citrulline amino acid (which can be generated post-translationally from arginine) is a critically important moiety of the antigenic determinants targeted by RA-specific autoantibodies [24] . Cyclic citrullinated peptides (CCPs) are widely used as antigenic targets in ELISA-based diagnostic tests for RA. The sensitivity and specificity are 71 and 99%, respectively [25] .
Experimental Conditions for Serum Measurements
Serum Samples
The sera were obtained from the Department of Rheumatology, University Hospital Nijmegen. Sera were collected from patients visiting the outpatient clinic who had been diagnosed as having RA according to the revised criteria of the American College of Rheumatology. To assess specificity further, we analyzed a group of serum samples from healthy individuals and groups of sera from patients with osteoarthritis and SLE, obtained from various clinics and hospitals. Sera were stored at À80 1C until used. Anti-CCP2 ELISA was performed by IMMUNOSCAN RA (Euro-Diagnostica, Arnhem, The Netherlands), in accordance with the manufacturer's instructions with the recommended 25 U ml À1 cut-off.
SPR Microarray Interaction Studies
SPR detects changes in refractive index in the hydrogel (200 nm) which is linked to the gold surface. Due to the small molecular weight of the synthetic peptides used (B1500 Da), the contrast of the immobilized array to the background is not high. To visualize the array for determining the ROIs, human IgG was also spotted. Incubation, washing and regeneration were performed in an automated way using liquid handling procedures (LHPs) in the instrument for biomolecular interaction sensing (IBIS iSPR, IBIS Technologies Hengelo, The Netherlands). A serum sample plug of 400 ml (diluted 1:50 in PBS, 0.03% Tween 20) was guided backwards and forwards over the array in a flow cell at a rate of 1 ml s À1 . The serum sample plug was surrounded by two air plugs to prevent the diffusion of serum components into the buffer. Between all steps the flow cell was rinsed with PBS, 0.03% Tween 20. The array was regenerated by injection of 400 ml of 10 mM glycine-HCl (pH 1.5) twice for 30 s. Two incubationregeneration cycles were completed before applying the sera in order to block non-specific binding sites and create an optimal reactive sensor surface. Analysis of the data were done using the software supplied.
Results and Discussion of Monitoring Analysis Cycles for Autoantibody Screening
In our proof-of-principle experiments, a 24-spot microarray containing human IgG, and also two different linear citrullinated peptides I and II and the corresponding control peptides (containing arginine instead of citrulline), were spotted (1 nl per spot) on the sensor surface. Because none of the peptides contained lysine residues, coupling is expected to occur exclusively via the N-terminal primary amino groups, thereby ensuring oriented, end-on immobilization of the peptides. One set of peptides was synthesized with a C-terminal biotin tag. These peptides were used to investigate possible differences in immobilization efficiency by assessing the SPR angle shift that resulted from incubation of the array with an anti-biotin antibody. The corresponding SPR angle shifts were 211 AE 10 m1 and 212 AE 12 m1 (m1 ¼ milli degree) for the citrullinated and arginine-containing peptide I, respectively. From these data, it can be concluded that there was no difference in immobilization efficiency between the two peptides. After placing the spotted sensor chip on top of the hemisphere prism in the flow cell-based instrument, self-defined liquid handling procedures (LHPs) were used to increase the inter-experiment reproducibility. Serum incubation, washing and regeneration were done in an automated manner. In the instrument an angle scan including the capture of up to 80 images is carried out in 8 s. When a spot meets the optimal SPR conditions, the reflected light at a certain ROI within this spot will reach a minimum value resulting in a dark spot. Images of the reflected light at three different scan angles after incubation with serum for 1 h are shown in Figure 7 .9. The SPR dip of each ROI can be visualized in a reflectivity versus angle plot as shown. The 0 m1 setting is an arbitrary value, which can be set before each individual experiment by manual adjustment over a range of 101 to obtain the best angle range. At an incident angle of À700 m1 the background area near the array is in resonance (left image), at -200 m1 the spots coated with the arginine control peptides are in resonance (middle image) and at 100 m1 the spots coated with citrullinated peptide I are in resonance (right image). By curve fitting of the reflected light intensities as a function of scan angles for each spot of the microarray, the exact value of the SPR dip angle in m1 can be calculated and plotted in a sensorgram (Figure 7 .10). As described above, the y-axis of the sensorgram does not represent an arbitrary reflectivity parameter, but contains the exact values for the SPR angle at maximum resonance. These exact SPR angles can be normalized for easy comparison of all the different sensorgrams of all the spots and are linearly correlated with the refractive index, corresponding to the mass of protein bound to the sensor surface. Figure 7 .10 shows the sensorgram of an analysis cycle obtained during incubation of the microarray with a RA serum. ROIs in a background region nearby the array and ROIs within the spots of immobilized human IgG and of two arginine-containing peptide I and II controls showed relatively small angle shifts. Binding to the two corresponding citrullinated peptides I and II, however, resulted in angle shifts of 400 and 250 m1, respectively. The intra-array variation was very low, as illustrated by the sensorgrams of the quadruplicate interactions shown in Figure 7 .10. The noise, i.e. the baseline difference in resonance angle between the highest and the lowest values, measured over 100 time points (1000 s) in one individual ROI, was 1.35 m1, making angle shifts of 3 m1 significant.
In Figure 7 .11, the repeatability of the serum interactions with the microarray by an automated liquid handling procedure is shown. At the start of the sensorgram, two injections of a 1% glycerol solution were made for sensor calibration purposes. The sensor chips could be used for up to 50 analysis cycles by treatment of the sensor surface with two repetitive incubations with 10 mM glycine-HCl (pH 1.5) for 30 s after each serum incubation step. Furthermore, alternating injections of normal sheep serum and three RA patient sera were performed. After completing these six serum incubations, the total protocol was repeated with the same injection sequence to determine the stability of the array. Sequential measurements of patient sera on a single spot showed variations of less than 5% in binding to the citrullinated peptide, even when six interaction-regeneration cycles were performed between the two sequential measurements. At the end the sensor surface was again calibrated with two injections of a 1% glycerol solution. One can observe that the baseline increases by 20 m1 after 12 injections. In Figure 7 .12, a typical sensorgram (raw data) is shown of seven analysis cycles of different RA sera of three RA patients and control sera without anti-CCP antibodies and normal control serum. In addition, the responses of an SLE patient serum and an osteoarthritis patient serum are shown. We tested 50 RA sera and 29 control sera (9 SLE patient sera; 10 osteoarthritis patient sera; 10 normal healthy control sera). The interaction of sera with the microarray was quantified by calculating the ratio between the angle shifts observed for the citrullinated peptide I and the corresponding arginine control peptide (hereafter designated C/R ratio) upon binding of serum antibodies. The mean C/R ratio obtained with scanning SPR microarray imaging for the RA sera which were tested positive in a CCP2-ELISA (RA CCP+) is 8.7. The C/R ratio for the RA-sera that were tested negative in the CCP2-ELISA (RA CCPÀ), normal controls, SLE patients and OA patients where between 0.9 and 1.2. A detailed study of these 79 patient sera with ELISA and SPR test results were published recently [27] .
The currently most widely applied target for the detection of anti-citrullinated protein antibodies, cyclic citrullinated peptides, are recognized by only about 70% of RA patients [23] . Due to the heterogeneity of the anti-citrullinated protein response in RA, the use of additional citrullinated peptides may allow the detection of such antibodies in patients that are not reactive with the peptides used in the CCP2 ELISA. The use of microarrays monitored by SPR imaging will facilitate the simultaneous detection of the various anti-citrullinated protein antibodies.
Features and Benefits of Monitoring Analysis
Cycles with SPR Imaging
Compared with fixed-angle based SPR imaging systems, the scanning mode of the IBIS system measures the relevant angle of the SPR dip, permitting valid comparison of ROIs and correction for bulk effects. Due to the integrated liquid handling system in combination with the X-Y-Z robot, it is possible to run the experiments automatically. Although in the past many autoantigens have been identified and characterized, to date most of the assays that have been developed to detect autoantibodies are ELISA based, thus allowing only separate analyses for each type of autoantibodies. The need for multiplex analysis systems has been emphasized by recent observations that the specificity of the detection of anti-CCP antibodies in RA patient sera can be increased by monitoring reactivities with both the citrulline-and arginine-containing peptides in parallel [26] . In all of the multianalyte autoantibody studies, a secondary antibody conjugate was necessary to visualize bound antibodies. Here, we show that SPR imaging of protein/peptide microarrays provides a method that allows one-step multi-analyte detection of autoantibodies in patient sera, which does not require additional reagents to visualize antibody binding. Additional advantages of this system are that the SPR dip angle scanning principle allows accurate and simultaneous monitoring of biomolecular interactions between molecules of varying masses and that the ligand-containing sensor chips can be efficiently regenerated and re-used. Although the sensitivity of detecting RA-specific autoantibodies by the scanning SPR microarray imaging system under the conditions applied in this study is slightly lower than that of the ELISA systems, we expect that further optimization will lead to similar sensitivities. Moreover, for the low-titered sera a signal amplification step, e.g. by using a (gold-labeled) secondary antibody, may raise the sensitivity to levels that allow positive signals for all anti-CCP autoantibody-containing sera.
The initial results obtained with 50 rheumatoid arthritis patient sera (and 29 control sera) proves that SPR imaging is a promising, multi-analyte label-free technique for the development of diagnostic tests. Although kinetic evaluation of the analysis cycle including the determination of the thermodynamic equilibria is beyond the scope of this chapter (see Chapters 4 and 5), the application of measuring analysis cycles of microarrays has been demonstrated for RA patient autoantibody detection. In order to quantify the response of RA patient sera, the ratio of the binding to the citrulline-and arginine-containing peptides is used. An accurate calculation of this ratio is obtained only by comparison of the SPR angle shifts (and not reflectivity) measured in the scanning SPR microarray imaging system.
Conclusion
In this chapter, the analysis cycle of a biomolecular interaction has been discussed, and exemplified by experiments using an SPR imaging instrument. The preferred assay format is a direct assay described by A + B # AB, while other formats can be used for specific cases generally where the molecular weight of the analyte is too low for direct detection. The challenge of the small intrinsic refractive index label of the analyte can be circumvented by using alternative assay formats: competition, inhibition or sandwich. Real-time monitoring of the binding of biomolecules using SPR imaging allows the analysis of association and dissociation rate constants for determination of the affinity constants of many biomolecular interactions. The imaging feature of the scanning SPR microarray technology is of importance to check the quality of the sensor surface and to carefully identify the regions of interest in order to obtain high reproducibility. In addition, the accurate measurement of the SPR dip angle for monitoring the presence of autoantibodies in sera of autoimmune patients allows the comparison of each curve (e.g. citrulline vs. arginine), including subtraction of the common mode effect (i.e. bulk shift jumps). Scanning SPR microarray imaging will be of great use in any field that requires multi-analyte detection in an automated analysis cycle.
Questions
1. After spotting a microarray of peptide ligands on a sensor surface for SPR imaging, it is wise to also immobilize a high molecular weight ligand. Why? 2. If a spot or selected ROI is not homogeneous, it will affect the shape of the SPR curve. How? Draw possible SPR dip curves. 3. Ligands can be spotted on the sensor surface in different concentrations.
However, the degree of immobilization caused by diffusion of the ligand to the surface is mass transport controlled. How is spotting of ligands to the surface in exact serial dilution possible? 4. Inspection of the surface at several angles is a strong feature of scanning angle imaging instruments. Describe the benefits. 5. In SPRI instruments, ligands can be diluted over the sensor surface, reference spots can be defined, positive and negative controls can be spotted and the ratios can be determined. Baseline correction, subtraction and ratio determinations can be applied in the kinetic evaluation process as shown in this chapter. Explain why scanning angle SPR imaging instruments show in principle higher reproducibility than fixed-angle SPR imaging instruments. Explain why reflectivity data (y-axis in a sensorgram) plotted as a function of time introduces artifacts. How can these artifacts be corrected?
